Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:22 AM
Ignite Modification Date:
2025-12-25 @ 2:22 AM
NCT ID:
NCT00114634
Eligibility Criteria:
Inclusion
1. This study will include pediatric patients, ages 4-17 years old with a biochemical diagnosis of Smith-Lemli-Opitz Syndrome (SLOS).
2. Only mild and classical patients will be enrolled.
3. This study will be open to include SLOS patients regardless of whether or not they are participating in another NIH protocol.
Exclusion
1. Patients with a history of egg allergy or intolerance will be excluded from this study.
2. Subjects must be well enough to be in a home setting.
3. Patients participating in our simvastatin protocol (03-CH-3225) will be excluded from this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
17 Years
Study:
NCT00114634
Study Brief:
Protocol Section:
NCT00114634